Skip to content

Visionairy Technologies

3 viewers · 30d

Total raised

$3.9M

+$3.9M this year

1 filing since 2026 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $3.9M
ROUNDS
1
INVESTORS
14
FOUNDED
2025
HQ
New York, NY
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
3

AI overview

Updated

Visionairy builds AI-powered practice software purpose-built for eye care practices. It connects to a practice's EHR under a Business Associate Agreement and analyzes clinical notes and billing data to surface patients who meet criteria for procedures, catch medical coding errors before they turn into denials, and report performance by provider, location, or group. The company positions itself as a revenue engine for ophthalmology and optometry practices, from single providers to multi-location groups.

What sets it apart

Purpose-built for eye care rather than general-purpose practice management: it reads ophthalmology clinical notes to flag procedure candidates (SLT, punctal occlusion, visual field, blepharoplasty, MIGS) against each practice's own preferences, and is founded by a Yale-trained ophthalmologist.

Funding history

1 round
EquityFeb 5, 2026
Form D
+$3.9M$3.9M total

Latest SEC filings

via EDGAR · CIK 0002079102
Form D · Feb 5, 2026View on EDGAR

Products

1 tracked

Visionairy

Healthcare practice software

An AI platform that integrates with an eye care practice's EHR and analyzes patient and billing data across clinical tracking, coding, and analytics modules.

  • Clinical tracking that reads clinical notes to identify patients meeting criteria for procedures such as SLT, punctal occlusion, visual field, blepharoplasty, and MIGS
  • Customizable per-practice clinical criteria and preferences
  • Coding error detection with suggested corrections to prevent denials and adjustments
  • Analytics to query performance by provider, location, or group and track KPIs over time

Links

WebsiteLinkedInSEC EDGAR filings